Brief: Alzchem Confirms 2026 Forecast For Further Sales And EBITDA Growth
30/04/2026 05:59
April 30 (Reuters) - Alzchem Group AG ACT1.DE: EBITDA EUR 32.3 MILLION FORECAST 2026 FOR FURTHER SALES AND EBITDA GROWTH CONFIRMED Q1 2026 CONSOLIDATED SALES EUR 148.7 MILLION, UP 3% YEAR-ON-YEAR Q1 2026 EBITDA EUR 32.3 MILLION, MARGIN 21.7% VERSUS 18.9% PRIOR YEAR CONFIRMS 2026 FORECAST FOR FURTHER SALES AND EBITDA GROWTH Source text: ID:nEQ9PvBlqa Further company coverage: ACT1.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on AlzChem AG
See all newsGermany's Alzchem H1 sales rise on strong demand for specialty chemical ingredients
Brief: Alzchem Confirms Full-year 2026 Outlook
Brief: Alzchem Selects Bushy Park, South Carolina For Nitroguanidine Production Facility
Germany's Alzchem jumps 6.5% after defence contractor CSG secures 20% stake
Brief: Alzchem Group AG Further Increase In Shareholding By Czechoslovak Group